Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor
In conclusion, the classical clinical paradigm of lipids-modifying treatment should be changed and high TG should be recognized as an important target for therapy in their own right. Hypertriglyceridemia should be treated.
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Alexander TenenbaumRobert KlempfnerEnrique Fisman Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Epidemiology | Fenofibrate | Gemfibrozil | Genetics | Heart | Insulin | Metabolic Syndrome | Obesity | Statin Therapy | Study | Tricor | Vytorin | Zetia